EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
DEOXYCYTIDINE;
DRUG COMBINATION;
ORGANOPHOSPHORUS COMPOUND;
ABDOMINAL PAIN;
CHEMOPROPHYLAXIS;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
HEADACHE;
HEPATOMEGALY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
LACTIC ACIDOSIS;
MEDICATION COMPLIANCE;
NAUSEA;
NOTE;
SIDE EFFECT;
STEATOSIS;
VOMITING;
WEIGHT REDUCTION;
ANALOGS AND DERIVATIVES;
DRUG ADMINISTRATION;
DRUG COMBINATION;
ECONOMICS;
HIV INFECTIONS;
HUMAN IMMUNODEFICIENCY VIRUS 1;
TREATMENT OUTCOME;
UNITED STATES;
ANTI-HIV AGENTS;
DEOXYCYTIDINE;
DRUG ADMINISTRATION SCHEDULE;
DRUG COMBINATIONS;
DRUG COSTS;
HIV INFECTIONS;
HIV-1;
HUMANS;
ORGANOPHOSPHORUS COMPOUNDS;
TREATMENT OUTCOME;
UNITED STATES;
Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC). Interim guidance for clinicians considering the use of preexposure prophylaxis for the prevention of HIV infection in heterosexually active adults. MMWR Morb Mortal Wkly Rep. 2012;61(31):586-589.
TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana
Thigpen MC, Kebaabetswe PM, Paxton LA, et al.; TDF2 Study Group. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423-434.
iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
Grant RM, Lama JR, Anderson PL, et al.; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-2599.
(2010)N Engl J Med, vol.363, Issue.27, pp. 2587-2599
Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women
Baeten JM, Donnell D, Ndase P, et al.; Partners PrEP Study Team. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
Highlights of prescribing information, Foster City, Calif.: Gilead Sciences, Inc. Revised June, Accessed June 28, 2013
Highlights of prescribing information. Truvada (emtri-citabine/tenofovir disoproxil fumarate) tablets for oral use. Foster City, Calif.: Gilead Sciences, Inc. Revised June 2013. http://www.gilead.com/pdf/truvada_pi.pdf. Accessed June 28, 2013.
published ahead of print March 11, J Acquir Immune Defic Syndr, subscription required, Accessed August 1, 2013
Liu AY, Vittinghoff E, Chillag K, et al. Sexual risk behavior among HIV-uninfected men who have sex with men (MSM) participating in a tenofovir pre-exposure prophylaxis (PrEP) randomized trial in the United States [published ahead of print March 11, 2013]. J Acquir Immune Defic Syndr. http://journals.lww.com/jaids/Abstract/publishahead/Sexual_risk_behavior_among_ HIV_uninfected_men_who.98249.aspx (subscription required). Accessed August 1, 2013.
